ESASO MEMBER NETWORK

TBC Soosan Jacob
Published: Wednesday, June 8, 2016
The European School for Advanced Studies in Ophthalmology (ESASO) has established itself as a talent hub and first-rate educational institution of international appeal and reputation.
Since its foundation in 2008, ESASO has trained over 1,700 young ophthalmologists in advanced scientific and clinical skills for the benefit of their patients. Particularly well-appreciated and well-attended are the annual Retina Academies with their high-level intellectual and social spirit, world-class faculty and creative session formats.
These recurrent educational conferences always cover the latest developments in eye science, diagnosis and treatment, in a particularly supportive and engaging learning environment. ESASO’s five-full-week modules are another highlight, from which 60 graduates with a postgraduate diploma of Specialist Superior in Ophthalmology (DiSSO) have emerged so far. Eight ESASO fellows have received financial, organisational and advisory support for one year, to develop their skills as a guest at prestigious academic and clinical institutions.
ESASO wishes to further support the young talents who attended the academies, modules and advanced courses. We are thus strongly determined to promote the network of alumni and members. This evolving and expanding community will provide ever better chances for organised and self-organised connections in the ESASO spirit, for further exchanging with colleagues and leaders in the field by mail and in person.
ESASO is now offering a membership to its network, to contribute as well as receive ideas, and to initiate activities as well as assist and support members’ initiatives. Opportunities include continuing medical education, congress participation, publications and research, as well as tools to support your professional career. These tools will address topics such as technical innovation, publication support, hospital management, presentation skills, patient reports, good clinical practice, compliance, among others.
We encourage, support and organise activities of all kinds and formats, to benefit from all possible synergies. We offer face-to-face educational modules as well as moderated webcast training of the type “ESASO eMasterClass”, and will potentially organise a Young Ophthalmologists Forum during the annual Retina Academy congress.
The ESASO global member network can potentially connect you with 7,500 colleagues, and will develop and grow as an integral part of the already flourishing international ESASO community and network, which includes over 180 leaders in ophthalmology and a multitude of renowned universities and clinics from across the world.
“Enhancing and developing the member network to full bloom is the next step and level to fill ESASO’s vision of collaboration with life. We are ardently dedicated to developing the member network into an even more vibrant community with benefits for all, and lots of extra values,” says Giuseppe Guarnaccia, Global Executive Director of ESASO.
For further information and membership forms, please visit: www.esaso.org
Latest Articles
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.